APA (7th ed.) Citation

CC, W., PJ, R., NK, W., RP, S., N, R., JS, S., . . . R, R. (2021). Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy. Ophthalmology, 128(9), 1325. https://doi.org/10.1016/j.ophtha.2021.02.025

Chicago Style (17th ed.) Citation

CC, Wykoff, et al. "Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy." Ophthalmology 128, no. 9 (2021): 1325. https://doi.org/10.1016/j.ophtha.2021.02.025.

MLA (9th ed.) Citation

CC, Wykoff, et al. "Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy." Ophthalmology, vol. 128, no. 9, 2021, p. 1325, https://doi.org/10.1016/j.ophtha.2021.02.025.